AMICET SYRUP is a combination of Ambroxol and Levocetirizine, which belong to the group of medicines called Mucolytics and Antihistamines, respectively. It is used to provide symptomatic relief for allergic bronchitis and asthma-associated allergic rhinitis in adults and children (aged 6 years and older).
Allergic bronchitis is a condition that occurs due to inflammation of the bronchial tubes by an allergic reaction and is generally characterized by symptoms such as cough, wheezing, chest tightness, and weakness. Allergic asthma is a breathing condition where the airways tighten when an allergen is inhaled, such as pollen or mold spores, and is generally characterized by symptoms such as shortness of breath, coughing, wheezing, and a stuffy nose.
Avoid taking AMICET SYRUP if you are allergic to ambroxol, levocetirizine, or cetirizine or have end-stage renal disease (kidney failure). Before taking AMICET SYRUP, inform your doctor if you have liver problems, such as hepatic impairment.
AMICET SYRUP is not recommended for use during pregnancy or in breastfeeding women, as it can pass through breastmilk. AMICET SYRUP is not recommended for use in children (aged 6 to 11 years) with impaired renal function, and it is used with caution in children and adolescents (aged below 18 years) after consulting the doctor.
The most common side effects of taking AMICET SYRUP are headaches, excessive sleepiness, dry mouth, weakness, and decreased muscle strength. Consult your doctor if any of the side effects worsen.
No content available
